share_log

基石藥業-B:自願公告 - 基石藥業在2023年ESMO年會上以口頭報告形式公佈舒格利單抗一線治療胃/胃食管結合部腺癌的註冊性臨床研究數據

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE SHOWCASED, IN AN ORAL SESSION, LATE-BREAKING RESULTS FROM PHASE 3 STUDY OF SUGEMALIMAB IN FIRST-LINE GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AT ESMO 2023

香港交易所 ·  Oct 24, 2023 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more